Doctors have known for years that the incidence of deadly liver cancer is on the rise, but what is causing that trend has remained a mystery. Two recent studies offer a clearer picture of the rise of hepatocellular carcinoma, or liver cancer, which has tripled in the IS in the last three decades and has a 10 to 12 percent five-year survival rate when detected in later stages.